GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Lessened by Moors & Cabot Inc.

Moors & Cabot Inc. cut its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,775 shares of the company’s stock after selling 125 shares during the quarter. Moors & Cabot Inc.’s holdings in GE HealthCare Technologies were worth $764,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of GEHC. Assetmark Inc. boosted its position in shares of GE HealthCare Technologies by 37.0% in the 3rd quarter. Assetmark Inc. now owns 2,697 shares of the company’s stock valued at $253,000 after purchasing an additional 729 shares during the period. Atria Investments Inc boosted its holdings in shares of GE HealthCare Technologies by 15.2% in the third quarter. Atria Investments Inc now owns 11,833 shares of the company’s stock worth $1,111,000 after buying an additional 1,565 shares during the period. Sigma Planning Corp increased its position in shares of GE HealthCare Technologies by 5.9% in the third quarter. Sigma Planning Corp now owns 5,950 shares of the company’s stock worth $558,000 after acquiring an additional 330 shares in the last quarter. Axxcess Wealth Management LLC acquired a new stake in shares of GE HealthCare Technologies during the third quarter valued at approximately $207,000. Finally, Crossmark Global Holdings Inc. lifted its position in shares of GE HealthCare Technologies by 24.1% in the 3rd quarter. Crossmark Global Holdings Inc. now owns 9,267 shares of the company’s stock valued at $870,000 after acquiring an additional 1,801 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $81.97 on Friday. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $37.48 billion, a PE ratio of 18.93, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a 50 day moving average price of $87.26 and a two-hundred day moving average price of $86.10.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. As a group, equities analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on GEHC. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $85.00 to $100.00 in a research report on Tuesday. Citigroup raised their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research report on Thursday, February 13th. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.